Health CanadaGeneral Alert

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

Name: OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
Brand: Marketed health products
SKU: CANADA-72307
Availability: Discontinued
Rating: 1.0 (1 reviews)

Published: December 5, 2022Recall ID: 72307Category: generalCountry: Canada

Safety AlertHealth Canada Canada

Canada

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

Recalling Firm: Marketed health products

Reason for Recall / Hazard

New safety information

Product Description & Identification

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

Affected Products

OCALIVA (obeticholic acid)

Additional Source Details

Field	Value
N I D	72307
U R L	https://recalls-rappels.canada.ca/en/alert-recall/ocaliva-obeticholic-acid-new-contraindication-treatment-primary-biliary-cholangitis
Issue	New safety information
Title	OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
Product	OCALIVA (obeticholic acid)
Archived	0
Category	Drugs
Last updated	2022-12-05
Organization	Marketed health products

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode Scanner VIN Vehicle Check Pantry Safety Audit

Overview

Recalling FirmMarketed health products

Recall Hazard Severity

Caution (Class III)

Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Marketed health products - OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

Check if your household is affected:
https://therecallfile.com/recalls/ocaliva-obeticholic-acid-new-contraindication-for-the-treatment-of-pri/CANADA-72307

WhatsApp Facebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Spread the WordOCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

Reason for Recall / Hazard

Product Description & Identification

Affected Products

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Install The Recall File App

Notification

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)

Reason for Recall / Hazard

Product Description & Identification

Affected Products

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Related Recalls

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018409 -

Transport Canada Recall - 2018409 -

Install The Recall File App

Notification